Nanobiotix S.A. / Fundamentals
Income statement
- Net revenue
€24.60M - Cost of goods sold
-€2.12M - Gross profit
€26.72M - SG&A expenses
€41.94M - R&D expenses
€78.36M - EBITDA
-€95.64M - D&A
€2.64M - EBIT
-€98.47M - Interest expenses
€8.09M - EBT
-€109.22M - Tax expenses
-€1.38M - Net income
-€107.83M
Cash flow statement
- Net deferred tax
-€259.00K - Non-cash items
€40.02M - Changes in working capital
€21.24M - Operating cash flow
-€32.33M - Capex
€1.18M - Other investing cash flow
-€130.00K - Net investing cash flow
-€1.30M - Total cash dividends paid
€0.00 - Issuance of common stock
€57.36M - Debt repayment
-€5.60M - Other financing cash flow
€47.54M - Net financing cash flow
€41.94M - Foreign exchange effects
€43.00K - Net change in cash
€86.44M - Cash at end of period
€49.74M - Free cash flow
-€31.15M
Balance sheet
- Cash and cash equivalents
€49.74M - Cash and short-term investments
€49.74M - Total receivables
€8.54M - Inventory
€0.00 - Other current assets
€3.19M - Total current assets
€61.47M - Property, plant & equipment
€5.54M - Goodwill
€0.00 - Intangible assets
€7.00K - Long-term investments
€0.00 - Other non-current assets
€406.00K - Total non-current assets
€5.95M - Total assets
€67.42M - Accounts payable
€4.48M - Short-term debt
€4.92M - Other current liabilities
€24.50M - Total current liabilities
€58.94M - Long-term debt
€45.98M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€28.21M - Total non-current liabilities
€74.19M - Total liabilities
€133.12M - Common stock
€1.42M - Retained earnings
-€68.13M - Other equity
-€311.51M - Total equity
-€65.70M - Total liabilities and shareholders' equity
€67.42M
Company information
- Market capitalization
€187.74M - Employees
108 - Enterprise Value
€216.70M
Company ratios
- Gross margin
-
108.6% Much better than peer group: 9.8% - EBITDA margin
-
-388.8% Even with peer group: -385.2% - EBIT margin
-
-400.3% Even with peer group: -397.0% - EBT margin
-
-444.0% Much worse than peer group: -418.1% - Net margin
-
-438.4% Much worse than peer group: -380.0% - ROE
-
164.1% Much better than peer group: -53.6% - ROA
-
-159.9% Much worse than peer group: -33.1% - Asset turnover
-
36.5% Better than peer group: 27.1% - FCF margin
-
-136.2% Much better than peer group: -246.0% - FCF yield
-17.8% - Efficiency ratio
488.8% - Net sales per employee
-
€227.77K - Net income per employee
-
-€998.44K